Skip to main content
    I

    Illumina Inc (ILMN)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $198.00
    -9.01 (-4.35%)

    Market Cap: $31.30B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Illumina Inc (ILMN) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    Illumina reported revenue of $4.34B for the fiscal year ended Dec 31, 2025, down 0.7% from the year before. That year, net income was $850.00M with a net margin of 19.6%, operating cash flow was $1.08B and free cash flow was $931.00M. The quarter ended Sep 30, 2026 had revenue of $1.13B and net income of $220.00M.

    Revenue and Margins

    The operating margin was 18.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $2.40B, a compound annual rate of 6.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$4.34B-0.7%66.1%18.6%19.6%
    Dec 2024$4.37B-2.9%65.4%-19.1%-28.0%
    Dec 2023$4.50B-1.7%60.9%-23.7%-25.8%
    Dec 2022$4.58B+1.3%64.8%-91.2%-96.1%
    Dec 2021$4.53B+39.7%69.7%-2.7%16.8%
    Dec 2020$3.24B-8.6%68.0%17.9%20.3%
    Dec 2019$3.54B+6.3%69.6%27.8%27.9%
    Dec 2018$3.33B+21.1%69.0%26.5%23.5%
    Dec 2017$2.75B+14.8%66.4%22.0%24.6%
    Dec 2016$2.40BN/A69.5%24.5%17.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 46.7% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$4.34B$4.37B$4.50B$4.58B$4.53B$3.24B$3.54B$3.33B$2.75B$2.40B
    Cost of revenue$1.47B$1.51B$1.76B$1.61B$1.37B$1.04B$1.08B$1.03B$926.00M$732.00M
    Gross profit$2.87B$2.86B$2.74B$2.97B$3.15B$2.20B$2.47B$2.30B$1.83B$1.67B
    Research and development$967.00M$1.17B$1.35B$1.32B$1.19B$682.00M$647.00M$623.00M$546.00M$504.00M
    Operating income$807.00M-$833.00M-$1.07B-$4.18B-$123.00M$580.00M$985.00M$883.00M$606.00M$587.00M
    Net income$850.00M-$1.22B-$1.16B-$4.40B$762.00M$656.00M$990.00M$782.00M$678.00M$428.00M
    EBITDA$1.42B-$771.00M-$666.00M-$3.93B$1.23B$1.09B$1.33B$1.13B$1.25B$755.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.13B$1.16B$1.09B$1.16B$1.08B$1.06B$1.04B$1.10B$1.08B$1.11B$1.08B$1.12B
    Gross profit$830.00M$770.00M$721.00M$759.00M$733.00M$695.00M$683.00M$728.00M$745.00M$721.00M$667.00M$673.00M
    Operating income$305.00M$245.00M$209.00M$202.00M$227.00M$214.00M$164.00M$174.00M$741.00M-$1.64B-$111.00M-$163.00M
    Net income$220.00M$207.00M$134.00M$334.00M$150.00M$235.00M$131.00M$186.00M$705.00M-$1.99B-$126.00M-$176.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.99B exceeded cash and equivalents by $571.00M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$6.64B$6.30B$10.11B$12.25B$15.22B$7.58B$7.32B$6.96B$5.26B$4.28B
    Current assets$3.29B$2.75B$2.61B$3.56B$2.71B$4.48B$4.45B$4.49B$2.98B$2.32B
    Cash and equivalents$1.42B$1.13B$1.05B$2.01B$1.23B$1.81B$2.04B$1.14B$1.23B$735.00M
    Total liabilities$3.92B$3.93B$4.37B$5.65B$4.48B$2.89B$2.70B$3.05B$2.29B$1.97B
    Short-term debt$499.00M$499.00M$0$1.25B$0$511.00M$0$1.11B$10.00M$2.00M
    Long-term debt$1.49B$1.49B$1.49B$1.49B$1.70B$673.00M$1.14B$890.00M$1.18B$1.06B
    Shareholder equity$2.72B$2.37B$5.75B$6.60B$10.74B$4.69B$4.61B$3.76B$2.75B$2.20B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$6.81B$6.65B$6.56B$6.64B$6.18B$6.09B$6.18B$6.30B$6.01B$6.08B$10.04B$10.11B
    Total liabilities$3.67B$3.81B$3.88B$3.92B$3.80B$3.83B$3.81B$3.93B$3.89B$4.64B$4.31B$4.37B
    Cash and equivalents$1.29B$1.04B$1.09B$1.42B$1.05B$934.00M$1.11B$1.13B$869.00M$920.00M$1.11B$1.05B
    Shareholder equity$3.15B$2.84B$2.68B$2.72B$2.38B$2.26B$2.37B$2.37B$2.13B$1.44B$5.73B$5.75B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 86.2% of operating cash flow. Dividends and share repurchases together came to 79.8% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$1.08B$837.00M$478.00M$392.00M$545.00M$1.08B$1.05B$1.14B$875.00M$779.00M
    Capital expenditures$148.00M$128.00M$195.00M$286.00M$208.00M$189.00M$209.00M$296.00M$310.00M$260.00M
    Free cash flow$931.00M$709.00M$283.00M$106.00M$337.00M$891.00M$842.00M$846.00M$565.00M$519.00M
    Dividends paid$1.00M$1.00M$1.00M$0$511.00MN/AN/A$735.00M$3.00M$29.00M
    Share repurchases$742.00M$116.00M$0$0N/A$736.00M$324.00M$201.00M$251.00M$249.00M
    Investing cash flow-$55.00M-$178.00M-$231.00M-$591.00M-$1.07B-$554.00M$745.00M-$1.81B-$214.00M-$515.00M
    Financing cash flow-$744.00M-$570.00M-$1.21B$1.00B-$51.00M-$766.00M-$897.00M$594.00M-$176.00M-$296.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$419.00M$201.00M$289.00M$321.00M$284.00M$234.00M$240.00M$364.00M$316.00M$80.00M$77.00M$224.00M
    Capital expenditures$40.00M$40.00M$38.00M$55.00M$31.00M$30.00M$32.00M$29.00M$32.00M$31.00M$36.00M$51.00M
    Free cash flow$379.00M$161.00M$251.00M$266.00M$253.00M$204.00M$208.00M$335.00M$284.00M$49.00M$41.00M$173.00M
    Last 12 quarters

    Frequently Asked Questions About ILMN

    What is Illumina's annual revenue?

    Illumina reported revenue of $4.34B for the fiscal year ended Dec 31, 2025.

    How fast is Illumina's revenue growing?

    Revenue was down 0.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.8%.

    Is Illumina profitable?

    Yes. Illumina reported net income of $850.00M for the fiscal year ended Dec 31, 2025, with a net margin of 19.6%.

    How much free cash flow does ILMN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.08B minus capital expenditures of $148.00M produced free cash flow of $931.00M.

    How much debt does Illumina have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.49B, short-term debt of $499.00M and cash and equivalents of $1.42B.